3 ms·
From what I’ve read (the FDA website is fantastic), it’s an issue, but not a huge one. Valisure said “these levels are too high”, the FDA came back with “you’r
by refurb 7y ago
From what I’ve read (the FDA website is fantastic), it’s an issue, but not a huge one.
Valisure said “these levels are too high”, the FDA came back with “you’re testing it wrong”, so the FDA retested and determined a few of the drugs has higher than allowed NDMA, but we’re talking 10-50% too high (of a very small limit), not the 20,000% too high that Valisure claimed.
My guess is the FDA will institute new guidelines on testing, manufacturers will change their processes and ranitidine will come back in a year or so.
- internet_user 7y agonitrosamines are nasty stuff in general. I would not be surprised this ends up in revision of safe levels.